Detalles de la búsqueda
1.
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
Ann Intern Med
; 168(7): 461-470, 2018 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29459949
2.
Early Diagnosis of Pancreatic Cancer via Machine Learning Analysis of a National Electronic Medical Record Database.
JCO Clin Cancer Inform
; 7: e2300076, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37816199
3.
Efficacy and safety of ofatumumab and bendamustine followed by ofatumumab maintenance in patients with relapsed indolent non-Hodgkin lymphoma after prior rituximab.
Leuk Lymphoma
; 62(6): 1353-1360, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33448893
4.
Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update.
Leukemia
; 35(6): 1631-1642, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33980976
5.
Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial.
Lancet Haematol
; 3(12): e581-e591, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27890073
Resultados
1 -
5
de 5
1
Próxima >
>>